StayCurrentMD · Clinical Characteristics, Treatment, and Prognosis of Undifferentiated Embryonal Sarcoma of the Liver in Children: A retrospective study from four hospitals in China
Follow
Article1 min read·Published Nov 2025

Clinical Characteristics, Treatment, and Prognosis of Undifferentiated Embryonal Sarcoma of the Liver in Children: A retrospective study from four hospitals in China

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Nov 2025 · 1 min read

In brief

In brief

This retrospective multicenter study examines undifferentiated embryonal sarcoma of the liver (UESL), a rare aggressive malignancy in children. The research analyzes clinical presentations, treatment approaches, and outcomes across four Chinese hospitals to inform diagnostic and therapeutic strategies for this challenging pediatric liver tumor.

  • - UESL is a rare, aggressive pediatric liver malignancy requiring high clinical suspicion for timely diagnosis. - Multi-institutional data from China provides evidence-based insights for managing this uncommon tumor. - Complete surgical resection remains the cornerstone of curative treatment for UESL in children. - Chemotherapy plays a critical role in improving outcomes, particularly in advanced or unresectable cases. - Prognosis varies significantly; early detection and aggressive multimodal therapy improve survival rates.

Written by the GCMD Library team from the article.

Undifferentiated embryonal sarcoma of the liver (UESL) is a rare and aggressive pediatric malignancy. This study aims to provide clinical evidence for the diagnosis and treatment of UESL.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →